Skip to content
DataLookout
Menu

DemonsTTRateNCT07358078

DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Trial sites expanded: 24 → 27 locations
    • Eligibility criteria expanded, about 3 words
  2. Minor Trial sites expanded: 4 → 24 locationsv4
  3. Minor Study sites: 3 to 4v3
  4. Minor Study sites: 1 to 3v2
  5. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

New York Heart Association (NYHA) Class
Timeframe: From time of ATTR-CM diagnosis up to 5 years
Outpatient Diuretic Intensification
Timeframe: From time of enrollment for up to 5 years
Norfolk Quality of Life - Diabetic Neuropathy (QOL-DN) Total Score
Timeframe: From time of enrollment (if available) or ATTR-CM diagnosis up to 5 years
Kansas City Cardiomyopathy Questionnaire (KCCQ)
Timeframe: From time of enrollment (if available) or ATTR-CM diagnosis up to 5 years
Patient Global Impressions - Change (PGI-C)
Timeframe: From time of enrollment (if available) or ATTR-CM diagnosis up to 5 years
Patient Global Impressions - Severity (PGI-S);
Timeframe: From time of enrollment (if available) or ATTR-CM diagnosis up to 5 years
Treatment Satisfaction Questionnaire for Medication version 9 (TSQM-9)
Timeframe: From time of enrollment (if available) or ATTR-CM diagnosis up to 5 years

Arms and interventions

Patients with ATTR-CM

Patients with ATTR-CM.

Sites

27 sites in 3 countries

United States 13, Japan 10, Germany 4